The Relative Strength (RS) Rating for Concentra Group jumped into a higher percentile Friday, as it got a lift from 68 to 76.
This unique rating tracks technical performance by showing how a stock's price action over the last 52 weeks compares to that of the other stocks in our database.
Over 100 years of market history shows that the top-performing stocks tend to have an 80 or higher RS Rating in the early stages of their moves. See if Concentra Group can continue to rebound and hit that benchmark.
Can You Really Time The Stock Market?
Concentra Group is trying to complete a consolidation with a 24.80 buy point. See if the stock can break out in volume at least 40% higher than normal.
Earnings growth fell in the most recent quarter from -17% to -19%. But revenue gains moved higher, from 3% to 6%.
The company earns the No. 5 rank among its peers in the Medical-Managed Care industry group. Molina Healthcare is the top-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
